Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Preferred Shares: 2013-2025

Historic Preferred Shares for CorMedix (CRMD) over the last 10 years, with Sep 2025 value amounting to $92.

  • CorMedix's Preferred Shares fell 49.45% to $92 in Q3 2025 from the same period last year, while for Sep 2025 it was $92, marking a year-over-year decrease of 49.45%. This contributed to the annual value of $137 for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, CorMedix's Preferred Shares is $92, which was down 0.00% from $92 recorded in Q2 2025.
  • In the past 5 years, CorMedix's Preferred Shares ranged from a high of $182 in Q1 2021 and a low of $92 during Q1 2025.
  • For the 3-year period, CorMedix's Preferred Shares averaged around $150.50, with its median value being $182 (2024).
  • Data for CorMedix's Preferred Shares shows a maximum YoY slumped of 49.45% (in 2025) over the last 5 years.
  • Over the past 5 years, CorMedix's Preferred Shares (Quarterly) stood at $182 in 2021, then remained steady at $182 in 2022, then remained steady at $182 in 2023, then remained steady at $137 in 2024, then tumbled by 49.45% to $92 in 2025.
  • Its Preferred Shares stands at $92 for Q3 2025, versus $92 for Q2 2025 and $92 for Q1 2025.